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1. Introduction 
Concanavalin A, the phytohemagglutinin of jack 
bean (CQnQvQ~iQ ensiformis) precipitates various 
branched glycans by interacting with their terminal, 
non-reducing units [l] . 
Inhibition studies with the system dextran- 
concanavalin A have indicated that the specificity 
of the protein is directed primarily toward the C-3, 
C-4 and C-6 hydroxyl groups of D-mannopyranosyl 
or D-glucopyranosyl structures possessing an (Y-con- 
figuration at C-l. Modifications of the molecules at 
these sites cause disappearance of inhibitory activity. 
The hydroxyl group at C-2 seems to be also involved 
in the interaction, as indicated by the higher inhibi- 
tory activity of D-mannose in respect to D-glucose and 
by the lack of inhibitory activity of 2-acetamido-2- 
deoxy-D-mannose. 2-Acetamido-2-deoxy-D-glucose, 
however, has an inhibitory activity essentially similar 
to that of D-glucose, while the charged 2-amino-2- 
deoxy-D-glucose has none [ 1,2] . 
On the basis of this information, one would con- 
sider probable interaction between concanavalin A 
and glycosaminoglycans which contain, and may ter- 
minate, with non-reducing 2-acetamido-2-deoxy-D- 
glucose units possessing cu-configuration at position 1. 
Both heparin and heparan sulfate contain 2-acetamido- 
2-deoxy-D-glucose and 2-sulfamido-2-deoxy-D-glucose- 
6-sulfate [3] . The former amino sugar has been re- 
ported to be more abundant in the interior of the 
heparan sulfate or at the non-reducing terminus [4] . 
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Both polymers have cw41+4)-glycosidic linkages [3,5] 
and have been suspected of being branched rather 
than linear structures [6,7]. 
Two reports have appeared in the literature de- 
scribing the interaction of concanavalin A with hepa- 
rin. The first one [8] stated that sodium heparinate 
had 50% more precipitating ability than a standard 
preparation of normal human liver glycogen. This 
ability to interact with concanavalin A was apparently 
unrelated to the sulfate groups of heparin, since it 
did not disappear upon desulfation and acetylation 
of the polymer nor when the polymer was partially 
deacetylated to give N-acetyl desulfated heparin. The 
second report [9] stated that commercially obtained 
heparin had 35% of the affinity of glycogen for con- 
canavalin A and that the interaction could be inhi- 
bited completely by 1 M NaCl and decreased 50% 
by 0.1 M glucose. These data imply that the inter- 
action between heparin and concanavalin A depends 
in part on electrostatic forces, a conclusion which is 
in contrast with the results obtained by Cifonelli et 
al. [8] using desulfated heparin. 
We have undertaken these experiments in order 
to investigate the possibility of identifying heparin 
and heparan sulfate in biological fluids, using conca- 
navalin A as a specific reagent. Under the experimen- 
tal conditions employed, no interaction between con- 
canavalin A and these glycosaminoglycans was de- 
tected. 
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2. Materials and methods 
Concanavalin A was prepared from 2 kg whole jack 
beans (Sigma Chemical Co., St. Louis, MO.) accord- 
ing to Doyle’s technique [9] with the following dif- 
ferences. After the elution of concanavalin A from 
Sephadex G-200 (Pharmacia Fine Chemicals, Piscata- 
way, NJ., USA) with 1 .O M glucose, dialysis of the 
eluate produced a large amount of precipitate which 
was removed by centrifugation and discarded. The 
clear supernatant was dialyzed exhaustively and then 
lyophilized. Upon solution in water, an insoluble 
sediment was again removed by centrifugation and 
the clear supernatant was lyophilized. The dry mate- 
rial obtained (1.37 g) was used for the experiments 
described. 
Rat liver glycogen was prepared with the method 
of Stetten et al. [lo]. Rabbit liver glycogen was pur- 
chased from Sigma Chemical Co. (Type III, No. C- 
8876, Lot 99B-0700). The following preparations of 
glycosaminoglycans were used: 
1) Heparin, sodium salt (Calbiochem Lot 63525, 
B grade). On analyses, it had hexuronic acid 32.5%, 
sulfur 9.1 O%, 2-sulfamido-2-deoxy-D-glucose 26.7%, 
neutral sugars (anthrone) 8%. The molecular weight, 
determined by sedimentation equilibrium, was 8,240. 
2) Heparin, potassium salt (gift of Dr. D.D.Dzie- 
wiatkowski, University of Michigan, Ann Arbor, Mich.) 
had carbon 21.5%, nitrogen 1.7%, sulfur 9.84%, ash 
46.5%, neutral sugars 5.8%, [a] k1 + 40”, molecular 
weight 11,000 + 1,000. 
3) Heparin (from hog mucosal tissues, fractionated 
by cetylpyridinium chloride precipitation; gift of Dr. 
J.A.Cifonelli, University of Chicago, Ill.) had nitrogen 
2.6% hexuronic acid 38.7%, hexosamine 23.8%, 
neutral sugars 8.6% and the following molar ratios to 
glucosamine taken as 1.00: sulfate 2.33, galactosamine 
0.001, 2-sulfamido-2-deoxy-D-glucose 0.89; [CK] g + 
52”, molecular weight [l I] 11,000. 
4) Heparan sulfate, calcium salt (from beef lungs, 
purified by fractionation on Dowex 1 column; gift 
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Fig. 1. interaction between concanavalin A and rat liver glycogen (-), rabbit liver glycogen (- - - ) 
and various preparations of heparin and heparan sulfate (-) . 
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acid 44.1%, hexosamine 24.6% and the following 
molar ratios to glucosamine taken as 1 .OO: sulfate 
0.99, galactosamine 0.002, 2-sulfamido-2-deoxy-D- 
glucose 0.51; [a!] i4 + 73”. 
5) Heparan sulfate (gift of Dr. K.Von Berlepsch, 
Hoffman-Laroche, Basel, Switzerland, Lot Ro l- 
22321754). 
Each of these preparations was dissolved in pH 5.50 
acetate buffer 0.05 M, 0.10 M NaCl [9], to a concen- 
tration of 1 mg/ml. Concanavalin A was also dissolved 
in the buffer to a concentration of 4 mg/ml. Its reac- 
tivity with the various glycosaminoglycans was meas- 
ured with the method of Doyle et al. [9], adding 1 ml 
of the protein solution to decreasing amounts of each 
glycosaminoglycan in 1 ml of the buffer. 
3. Results and discussion 
The results reported in fig. 1 indicate that both 
preparations of glycogen reacted with concanavalin A 
but none of the glycosaminoglycans tested did so. 
Thus, our results disagree with those of Cifonelli et al. 
[8] and Doyle et al. [9]. 
One can only speculate on the reasons for these 
differences. Unfortunately, no analytical data of the 
heparin preparations used in the previous experiments 
were available, so that it is impossible to compare the 
relative purity of the various preparations or their 
physical properties. However, the fact that the hepa- 
rin preparation used by Doyle et al. [9] had an an- 
throne hexose value of 15.2% may indicate a possible 
contamination with other glycans. Our preparations 
of heparin had satisfactory analytical data, molecular 
weights and biological activities. Thus, it is not likely 
that the absence of interaction with concanavalin A 
might have been due to factors related to their size 
or shape [ 121 Rather, it is possible that despite the 
presence in these glycosaminoglycans of 2-acetamido- 
2-deoxy_D-glucose residues, these might have been 
too scarce on a molar basis or in the wrong site to 
assure a sufficient number of reactive sites for the 
binding with concanavalin A [ 121. While the inter- 
action of heparin and concanavalin A, as reported 
by Cifonelli et al. [8] did not seem to depend on 
electrostatic forces, that described by Doyle et al. 
[9] was dependent on them and could be prevented 
by 1 .O M NaCl. One wonders, then, whether the pres- 
ence of other protein, besides concanavalin A, in the 
Sephadex eluate might have been responsible for 
the interaction with heparin. The latter glycosamino- 
glycan is known for its ability to bind various pro- 
teins in absence of a sufficient concentration of 
counterions. 
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